Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Methylphenidate Extended Release in Patients With Schizophrenia: a Single-centre Fixed Dose Cross-over Open-label Trial to Improve Functional and Cognitive Outcomes

NCT05414058 is registered in ClinicalTrials.gov with The Royal Ottawa Mental Health Centre as lead sponsor.

NCT NCT05414058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05414058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Methylphenidate Extended Release in Patients With Schizophrenia: a Single-centre Fixed Dose Cross-over Open-label Trial to Improve Functional and Cognitive Outcomes
Lead sponsor
The Royal Ottawa Mental Health Centre
Phase
Phase 2
Overall status
Completed
Start date
September 9, 2022
Completion date
September 18, 2024
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia schizoaffective